Check out some of the biggest drivers in the front market:
Verizon (VZ) – Verizon earned quarterly earnings of $ 1.31 per share, 2 cents per share above estimates. Revenue also beat analysts’ forecasts. Verizon lost more wireless subscribers during the quarter than analysts had expected.
Welbilt (WBT) – Welbilt shares rose 14.8% in the aftermarket after professional food service equipment maker agreed to buy through rival Middleby (MIDD) in a $ 4.3 implicit stock deal billion.
Anthem (ANTM) – The health insurer earned $ 7.01 per share for its last quarter, beating estimates by 50 cents per share. The revenue did not come under Wall Street projections. Anthem also increased its outlook for the full year, amid growth in its various medical plans and higher revenue for pharmacy benefits. The share increased by 1.6% with the pre-sale.
Halliburton (HAL) – Halliburton shares climbed 2.4% in market action after beating estimates by 2 cents per share, with a quarterly gain of 19 cents per share. Revenue was also higher than estimated, and the oil field service company said the North American company was still healthy.
Baker Hughes (BKR) – The oilfield services company’s share rose 1.2% in market action after achieving quarterly earnings of 12 cents per share, one cent per share above the estimate. The revenue was essentially in line with expectations. Profits fell 40% from a year ago, affected by severe winter weather.
Nasdaq (NDAQ) – The stock exchange operator earned $ 1.96 per share for the first quarter, up 23 cents per share above estimates. The revenue also came above the street forecasts. The results were strengthened by the increase in the double digit in equities and fixed income. Nasdaq also announced a 10% dividend increase.
Netflix (NFLX) – Netflix tumbled 8.7% in market trading, even after last-quarter estimates hit both the top and bottom lines. Investors are focusing on the weaker numbers of subscribers for the video giant than expected.
CSX (CSX) – CSX fell below the estimates by 2 cents per share, with quarterly earnings of 93 cents per share. The revenue of the railway operator came above the forecasts. The interruptions of the pandemic and higher fuel costs have progressed at the core of CSX. CSX reduced 1% in pre-trading.
Moderna (MRNA) – The drugmaker’s shares rose 1.1% in pre-trade, following a new Covid-19 vaccine supply agreement with Israel for 2022. Israel has also been given an option to buy doses of vaccine is designed to treat specific variants of the virus.
Norwegian Cruise Line (NCLH) – Norwegian shares rose 2.4% in the pre-market after Goldman Sachs upgraded the cruise line operator to buy ‘neutral’. Goldman mentioned several positive factors, including the capacity growth and the low leverage of Norwegian compared to its peers.
Intuitive Surgical (ISRG) – Intuitive Surgical earned $ 3.52 per share for its last quarter, well above the $ 2.63 per share consensus estimate. The revenue of the surgical device manufacturer also beats predictions, and the procedures used by the company’s devices increase as the Covid-19 pandemic eases. The stock gained 3.9% in trading on the market.
ASML (ASML) – ASML rose 3.6% in market performance after reporting better-than-expected gains in the first quarter as semiconductor manufacturing equipment supplier benefits from global increase in disk demand . ASML has also increased its full year outlook.
Tenet Healthcare (THC) – Tenet showed a quarterly earnings of $ 1.30 per share, compared to 72 cents per consensus estimate. The hospital operator’s revenue came slightly above the forecast. Tenet said he was able to successfully handle challenges related to the pandemic and winter storms, and it also gave an optimistic outlook. Tenet added 2.7% to the pre-trade.
Interactive Brokers (IBKR) – Interactive brokers earned 7 cents per share above the estimate, with quarterly earnings of 98 cents per share. Revenue was much higher than the estimates on a 53% increase in commissions. The stock added 2.1% in market trading.
Edwards Lifesciences (EW) – Edwards shares rose 3.8% in the futures market after beating estimates by 7 cents per share, with a quarterly gain of 54 cents per share. Revenue was also higher than the consensus forecasts, and the medical device company also increased its annual forecast of the expected increase in demand for heart-related procedures.